Cinnaxole Pharma · raw details

Cinnaxole Pharma is developinga cinnamon-based, antiviral extract for vaccinationsagainst envelope virus diseases. The company's first product will be used for in-ovo vaccination against NewCastle disease, an infection affecting domestic poultry and other bird species. NewCastle disease is one of the most severe poultry diseases and there is currently noefficient in-ovo vaccination against it available in the market. Cinnaxole Pharma's solution will be more efficient and less costly than traditional vaccinations (spray, injection, and intranasal vaccinations). Cinnaxole Pharma will develop additional antiviral vaccinations and disease preventive products.